πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8481024

Vaccines against tularemia

The Regents of the University of California Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8476043

Inhibitors for the soluble epoxide hydrolase

The Regents of the University of California Β· Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8476451

Tubulysin D analogues

The Regents of the University of California Β· Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8470545

Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (

The Regents of the University of California Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8460651

Methods of treating amyotrophic lateral sclerosis (ALS)

The Regents of the University of California Β· Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8460653

Superoxide dismutase variants and methods of use thereof

The Regents of the University of California Β· Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8461298

Compositions and methods for modification of biomolecules

The Regents of the University of California Β· Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8454958

Methods for detecting and inhibiting angiogenesis

The Regents of the University of California Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8455553

Methods and compositions for prevention and treatment of inflammatory disease, autoimmune

The Regents of the University of California Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8450062

SOCS-3 promoter methylation in cancer

The Regents of the University of California Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8450481

Compounds for inhibiting protein aggregation, and methods for making and using them

The Regents of the University of California Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8449875

Targeting pseudotyped retroviral vectors

The Regents of the University of California Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8445632

Selective poly-N-substituted glycine antibiotics

The Regents of the University of California Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8445507

Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-ass

The Regents of the University of California Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8445021

Functionalized magnetic nanoparticles and methods of use thereof

The Regents of the University of California Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440621

Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

The Regents of the University of California Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440229

Hollow silica nanospheres and methods of making same

The Regents of the University of California Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8435941

Mini-hepcidin peptides and methods of using thereof

The Regents of the University of California Β· Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431561

Methods and compositions for treatment of excess nitric oxide or cyanide toxicity

The Regents of the University of California Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431558

Compositions and methods for modification of biomolecules

The Regents of the University of California Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8425930

Prebiotic oligosaccharides

The Regents of the University of California Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420852

Phospholipase A2 inhibitors and their use in treating neurological injury and disease

The Regents of the University of California Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420612

Diabetes treatment methods and drug targets therefor

The Regents of the University of California Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8415323

MicroRNAs for inhibiting viral replication

The Regents of the University of California Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted